< Back to Results

Central Nervous System

Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma
Unique Dataset IDnci-data-21DownloadableNo
NCI Description
The dataset NCT03015701-D1-Dataset.csv will allow users to reproduce efficacy analyses included in the aforementioned publication, which included primary and secondary efficacy results evaluating the mifepristone over placebo for the treatment of patients with unresectable meningioma in the SWOG phase III trial, S9005.
Clinical Trial Title
Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma
Trial Summary and Conditions
To compare daily oral mifepristone vs placebo with respect to time to treatment failure in patients with unresectable meningioma.
Data Summary
See data dictionary for more details.
Study Objectives
To compare daily oral mifepristone vs placebo with respect to time to treatment failure in patients with unresectable meningioma and to address issues of safety in this patient population.
Outcome Measures
Primary: Time to Treatment Failure [ Time Frame: 6 years ] Secondary: Incidence of Treatment-Emergent Adverse Events [ Time Frame: two years after beginning treatment ] Safety [ Time Frame: two years after beginning treatment ]
ClinicalTrial.gov
Below are the clinical trial(s) associated with this dataset (all links are to ClinicalTrials.Gov):
Available Downloads:
To gain access to the data and analytic tools click here.

Data Dictionary: NCT03015701-D1-Data-Dictionary.pdf

DATA: NCT03015701-D1-Dataset.csv

OTHER: README.pdf